Jun 26, 2023 10:10AM

Jun 6, 2023 05:26AM

Jun 6, 2023 04:00AM

May 24, 2023 09:40AM

May 24, 2023 06:23AM

Apr 27, 2023 07:39AM

Apr 27, 2023 07:39AM Zura Bio Announces $80 Million Financing and the Licensing of Tibulizumab (ZB-106), a Potential First-in-Class anti-IL-17 and anti-BAFF Dual Antagonist for Autoimmune Diseases

Mar 21, 2023 06:13AM

32,346 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All